An FDA complete response letter for idebenone in LHON indicates unresolved NDA deficiencies and necessitates additional data ...

US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter to Aldeyra Therapeutics for its New Drug Application of reproxalap for the treatment of dry eye dis ...

Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; ...

NovaBridge Biosciences and Visara have announced topline results from their phase 2a study of VIS-101 for retinal vascular ...

Reported accuracies were 86% (Random Forest) and 96% (convolutional neural networks), positioning retinal imaging as a candidate scalable tool for underserved populations. AI-powered polarized-light ...

Tattoo-associated uveitis was once considered rare; however, that appears to be no longer true, according to a new Australian ...

Following a second injection at eight weeks, the patient maintained stable vision and remained dry at 12 weeks, allowing for ...

The 51 st annual American Association for Pediatric Ophthalmology and Strabismus (AAPOS) meeting will convene from March 18 ...

Cross-sectional analysis of the prospective Low Vision Rehabilitation Outcomes Study included 28 US centers and assessed ...

MFDS IND approval enables a multicenter, randomized, double-blind, vehicle-controlled phase 2 study in ~150 DED patients, randomized 1:1:1 to two dosing arms versus control over 12 weeks. Prior phase ...

Desk workers reported 99.2 hours of weekly screen time, with weekday exposure comprising 93% of waking hours, underscoring ...